Biogen (BIIB) call put ratio 1.5 calls to 1 put with focus on April 235 calls after discontinuing Alzheimer's trials

March 21, 2019 10:07 AM

Biogen (NASDAQ: BIIB) call put ratio 1.5 calls to 1 put with focus on April 235 calls.

StreetInsider